Adaptimmune Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. 

CEO
Adrian Rawcliffe
CEOAdrian Rawcliffe
Employees
449
Employees449
Headquarters
Abingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded
2014
Founded2014
Employees
449
Employees449

ADAP Key Statistics

Market cap
148.39M
Market cap148.39M
Price-Earnings ratio
-2.70
Price-Earnings ratio-2.70
Dividend yield
—
Dividend yield—
Average volume
1.53M
Average volume1.53M
High today
$0.619
High today$0.619
Low today
$0.5688
Low today$0.5688
Open price
$0.5899
Open price$0.5899
Volume
619.28K
Volume619.28K
52 Week high
$2.05
52 Week high$2.05
52 Week low
$0.5316
52 Week low$0.5316

Analyst ratings

67%

of 9 ratings
Buy
66.7%
Hold
22.2%
Sell
11.1%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.